Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jdv.20857 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Differentiating Autonomic Denervation Dermatitis From Post-traumatic Eczema: A Case Series of Localized Eczematous Eruptions.
Cureus
July 2025
Dermatology, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.
Autonomic denervation dermatitis is a newly introduced term that describes the occurrence of a scaly eczematous lesion at the site of incision of a previous surgery. The time lag between the incision and the occurrence of the eczematous lesion varies greatly, ranging from months to years. Autonomic denervation dermatitis, by definition, can occur at any site of previous surgery; however, a few sites are specially named, like surgery of the knee, injury to the infrapatellar branch of the saphenous nerve, and traumatic eczematous dermatitis (SKINTED) occurring after total knee arthroplasty.
View Article and Find Full Text PDFElevated Cutaneous Interleukin-21 Links Eczematous Eruption to Interleukin-17A Inhibitor Treatment in Psoriasis.
Allergy
August 2025
Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Background: Eczematous eruption (EE) is an adverse effect observed in psoriasis patients undergoing interleukin (IL)-17A inhibitor therapy, with reported incidence rates ranging from 2.2% to 12.1%.
View Article and Find Full Text PDFLong-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response.
Dermatol Ther (Heidelb)
August 2025
Departamento de Dermatología, Hospital Universitario Virgen de las Nieves. Ibs, Granada, Spain.
Introduction: Hidradenitis suppurativa (HS) is a debilitating, chronic inflammatory skin disease that severely impacts patients' quality of life. Bimekizumab, the first dual inhibitor of interleukin (IL)-17A and IL-17F, has shown efficacy in phase 3 clinical trials and is currently approved for moderate-to-severe HS. However, long-term data in real-world clinical settings are lacking.
View Article and Find Full Text PDFClinical Presentation and Causes of Prosthesis-Related Hypersensitivity Reactions: An Analysis of 225 Patients.
Int Arch Allergy Immunol
August 2025
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Introduction: Between 10% and 20% of all prosthesis patients experience implant-related complications within 1-2 years following surgery. Hypersensitivity to components within the prosthesis is a possible cause of these complications.
Methods: This study aimed to investigate the characteristics of prosthesis-related hypersensitivity (PRH) and identify possible associated risk factors.
Immunohistopathological Analysis of Spongiosis Formation in Atopic Dermatitis Compared with Other Skin Diseases.
Dermatopathology (Basel)
August 2025
Department of Geriatric Pathology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi, Tokyo 173-0015, Japan.
Whether the spongiotic reaction caused by the interaction of keratinocytes, T-lymphocytes, inflammatory dendritic epidermal cells (IDECs), and Langerhans cells (LCs) observed in atopic dermatitis (AD) represents a common feature of spongiosis in various skin diseases remains unclear. We analyzed the characteristics of spongiosis in AD compared with those in other eczematous dermatitis and inflammatory skin diseases by using immunohistochemical methods. Infiltration of IDECs (CD11c+ cells and/or CD206+ cells) and T-lymphocytes, accompanied by degenerated keratinocytes and aggregated LCs (CD207+ cells), was frequently observed as a common feature of spongiosis in multiple conditions.
View Article and Find Full Text PDF